Tafenoquine exhibits no anti-malarial activity in CYP 2D knock-out mice when dosed at their ED 100 values (3 mg/kg) established in WT mice. Tafenoquine anti-malarial activity is partially restored in humanized/CYP 2D6 knock-in mice when tested at two times its ED 100 (6 mg/kg).